Some other detailed clinical features of the enrolled NSCLC patients in each study were illustrated in Supplementary Table S2, including clinical stage, histological type, PD-L1 expression status and driver gene mutation information. This evidence concerns the gene CD274 and non-small cell lung carcinoma.